Reporting current research with living systematic literature reviews

Oct 22, 2019

Written by Julie Fricke (Systematic Review Analyst) and Neil Webb (Head of Systematic Review)

Systematic Reviews – The Problem

Although considered the gold standard of quality research, systematic literature reviews (SLRs) are very resource intensive (e.g. long timeline, high budget) [1]. This, in combination with the broader issue that “research outpaces understanding,” SLRs get quickly out-of-date [2]. There is a challenge to create reliable evidence that keeps up with the fast pace of research output. Once an SLR is published, only a small portion of reviews are updated within 2 years of publication [3], and this inability to maintain currency leads to significant inaccuracy.  A 2007 study following up 100 SLRs (including 27 Cochrane Reviews) found that in 15 cases, new evidence warranting a “substantial change” in the conclusions had emerged within 12 months [4].

What are Living Systematic Reviews?

To better connect evidence and practice, living systematic reviews (LSRs) were developed. LSRs are high quality, up-to-date online summaries of health research that are updated as new research becomes available [2]. As described by the Cochrane Collaboration, this means that LSRs:

  1. Are underpinned by continual, active monitoring of the evidence (i.e. monthly searches)
  2. Immediately include any new important evidence (data, studies or information) that is identified
  3. Are supported by up-to-date communication about the status of the review and any new evidence being incorporated
  4. Should additionally include explicit, transparent and predefined decisions on:
    a. How frequently new evidence is sought and screened
    b. When and how new evidence is incorporated into the review

Production of Living Systematic Reviews

LSRs are feasible due to recent technological and data-related innovations, such as online platforms, linked data, and machine learning [5]. Advancements to enhance efficiency and review production, particularly to reduce duplication of effort, include [6]:

  1. Semi-automation to reduce manual development of key SR processes
    a. Database searching and eligibility assessment
    b. Data extraction/collection and risk of bias assessment
    c. Synthesis and reporting
  2. Data repositories
  3. Dynamic, online publication of a living document
    a. Continuous peer and editorial review
    b. Version numbers
    c. Updated authorship
  4. Human “crowds” (e.g. Cochrane Crowd online platform)

These technologies are still being generated, but multiple initiatives and expanding research groups are in place to aid in their development.

Overall, LSRs provide a new and cost saving approach to support the ongoing efforts to produce evidence that is both trustworthy and current [2].  They lend to the development of up-to-date and appropriate guidelines and improve the application of health technologies. Consultancies should consider LSRs as an option for evidence generation.

  1. Petticrew, M., Systematic Reviews in the Social Sciences: A Practical Guide. Counselling and Psychotherapy Research, 2006. 6(4): p. 304-305.
  2. Elliott, J.H., et al., Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med, 2014. 11(2): p. e1001603.
  3. Jadad, A.R., et al., Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA, 1998. 280(3): p. 278-80.
  4. Shojania, K., Sampson, M, Ansari, MT, Ji, J, Doucette, S, Moher, D, How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis. Annals of Internal Medicine, 2007: p. 224-233.
  5. Elliott, J.H. Exploiting innovations in technology to improve the efficiency of review production. in 20th Cochrane Colloquium. 2012. Auckland.
  6. Thomas, J., et al., Living systematic reviews: 2. Combining human and machine effort. J Clin Epidemiol, 2017. 91: p. 31-37.


More Insights

Newborn genome screening: implications for health technology assessments of new orphan drugs

Newborn genome screening: implications for health technology assessments of new orphan drugs

Written by Luke Parkes   Introduction Newborn screening (NBS) is an impactful public health initiative that enables the diagnosis of severe conditions in asymptomatic infants at birth. Typically, NBS programmes include testing for a ... Read more

Navigating the complexities of economic evaluation for health technology assessment in dermatology

Navigating the complexities of economic evaluation for health technology assessment in dermatology

Written by Benjamin Clark   As the body’s largest organ, the skin is affected by a vast number of diseases, with over 3,000 distinct dermatological conditions impacting more than 1.8 billion individuals globally at any time (1). With ... Read more

NICE refines the HST routing criteria: What you need to know

NICE refines the HST routing criteria: What you need to know

Written by Brian O'Toole   The National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies (HST) programme is designed to evaluate innovative treatments for rare and complex conditions. On 19th March ... Read more

Systematic review case study: scoping research to identify comparators

Systematic review case study: scoping research to identify comparators

Written by Sneha Bhadti and David Pritchett   Establishing a list of relevant comparators at the protocol development stage is a vital step in the systematic literature review (SLR) process. Scoping research during this stage can help ... Read more